Literature DB >> 12655164

Clinical features of acute pulmonary thromboembolism in younger patients.

Mizuhiro Arima1, Tatsuji Kanoh, Atsutoshi Takagi, Kosei Tanimoto, Tetsuya Oigawa, Shigeru Matsuda.   

Abstract

The incidence of acute pulmonary thromboembolism (APTE) in younger patients is extremely low compared with older patients, so the clinical features of these younger patients with APTE is unknown. In the present study, 8 patients with APTE who were less than 40 years old (YG) were compared with 40 patients who were more than 41 years of age (OG). All YG patients had coagulopathy compared with 3 patients in the OG (p<0.01). Deep venous thrombosis (DVT) occurred in all 8 patients in the YG compared with 19 patients in the OG (p<0.01). A higher incidence of patients whose symptoms occurred gradually was noted in the YG (p<0.05). There were no significant differences in clinical characteristics, initial symptoms, past history or other predisposing factors for venous thromboembolism between the 2 groups. Residual pulmonary hypertension was not noted in the YG. However, 1 patient in the YG had recurrent APTE, despite good warfarin control. This study demonstrated the frequency of gradual onset, coagulopathy and clinical signs of DVT in the YG and therefore more careful and long-term observation is necessary in such patients.

Entities:  

Mesh:

Year:  2003        PMID: 12655164     DOI: 10.1253/circj.67.330

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  3 in total

1.  Factor V leiden thrombophilia in a female collegiate soccer athlete: a case report.

Authors:  Kendra Erickson; Michael E Powers
Journal:  J Athl Train       Date:  2013-02-20       Impact factor: 2.860

Review 2.  Etiology, diagnosis, and pharmacologic treatment of pediatric pulmonary hypertension.

Authors:  Robert Tulloh
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

Review 3.  Treatment of pediatric pulmonary hypertension.

Authors:  Amy Hawkins; Robert Tulloh
Journal:  Vasc Health Risk Manag       Date:  2009-06-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.